NightHawk Biosciences

Innovating by leveraging our fully integrated ecosystem, to accelerate the creation of novel therapies that arm the immune system.

[Governor Laura Kelly @GovLauraKelly]

Today, we announced my administration's most significant economic development investment since I took office. Scorpion will bring 500 new, high-paying jobs to Manhattan and inject $650 million in business investment into the KS economy. This is a game-changer for our state.

[NightHawk Biosciences @NightHawk_Bio]

https://t.co/2lftCVbAEF

[NightHawk Biosciences @NightHawk_Bio]

Please join $HTBX on Tuesday at 10:30 AM EST for a planned livestream event highlighting new developments. Don’t miss this event:

https://t.co/M90679fY0t

[David V. Rosowsky, Ph.D. @DavidRosowsky]

Welcome Scorpion! Our university, our community, and our PEOPLE are excited to be your partners, your hometown, and your neighbors. Welcome to Manhappiness and K-State. A very special place! @KState @MHKChamber @HeatBiologics @KansasCommerce

[NightHawk Biosciences @NightHawk_Bio]

Please join $HTBX on Tuesday at 10:30 AM EST for a planned livestream event highlighting new developments. Don’t miss this event:

https://t.co/M90679fY0t

[NightHawk Biosciences @NightHawk_Bio]

Pleased to welcome Greg Burel, former Director of the Strategic National Stockpile (SNS), to $HBTX’s Biothreat Advisory Board: https://t.co/hBhSNXkYRD

[NightHawk Biosciences @NightHawk_Bio]

Heat Biologics is pleased to announce that we will move our listing to the @NYSE American, where we expect to begin trading on Monday, February 14 under the same $HTBX ticker symbol. For details, see our announcement: https://t.co/Mczpmad0az

[NightHawk Biosciences @NightHawk_Bio]

Join Bioprocess Online (@BioProcessOL) tomorrow, Tuesday Feb 1 at 11 a.m. ET, for a live interactive panel discussion with CEO @jeffwolfheatbio and two other biotech execs to discuss pandemic preparedness. Register here: https://t.co/1gqRvNtfSt

[NightHawk Biosciences @NightHawk_Bio]

Promising new preclinical data on our PTX-35 has been published in the American Journal of Transplantation (@amjtransplant). Data supports further study in inflammatory disease and transplantation tolerance. Learn more: https://t.co/OWw2RAmKTE

[Jeff Wolf @jeffwolf_NHWK]

Great time-lapse of our Scorpion clean room pods being installed in our San Antonio facility. The pods are #MadeinAmerica, as is all of our Scorpion manufacturing. Looking forward to a ribbon-cutting of our first manufacturing facility in the coming months. We're getting there!

[NightHawk Biosciences @NightHawk_Bio]

$HTBX is proud to deepen its commitment to #biosecurity with the acquisition of Elusys Therapeutics and their approved countermeasure for inhalation #anthrax. More here: https://t.co/UYxk0Gb8aH

[NightHawk Biosciences @NightHawk_Bio]

“RapidVax really presents a new paradigm in responding to biothreats,” said $HTBX CEO Jeff Wolf, in an interview with Homeland Preparedness News (@homelandprep). Learn more on how Heat is preparing to leverage RapidVax against emerging biological threats: https://t.co/mk9PDz4U2i

[NightHawk Biosciences @NightHawk_Bio]

Today, $HTBX unveiled its RapidVax® cellular vaccine platform, which is being designed to enable an accelerated response to a wide variety of infectious agents by providing a flexible “plug-and-play” vaccine platform. To learn more, click here: https://t.co/icDLw1H3MG

[NightHawk Biosciences @NightHawk_Bio]

We're pleased to welcome Paul Tebbey, Ph.D. as Senior Vice President of Product Development and Portfolio Strategy. Paul's experience in pharma & biotech includes several approved vaccines and therapies in immune-mediated disorders and infectious diseases: https://t.co/BAjkss5uUN

[NightHawk Biosciences @NightHawk_Bio]

David Lasseter, a member of our biothreat advisory board, spoke with @tteminWFED on The Federal Drive podcast about the need to prepare the U.S. for biological threats and future pandemics, and Heat's ongoing efforts to do so. Listen here: https://t.co/y6aZeZHlog @FederalNewsNet

[NightHawk Biosciences @NightHawk_Bio]

$HTBX's new biothreat advisory board is actively focused on improving U.S. pandemic preparedness. Read more in @biospace: https://t.co/N8Ho2WJSaF

[NightHawk Biosciences @NightHawk_Bio]

Today, $HTBX unveiled Skunkworx Bio, a new subsidiary focused on rapid drug discovery and validation. Skunkworx utilizes proprietary libraries of “Pocket Biologics” used to identify proteins that bind to druggable targets. Read more on the launch here: https://t.co/fIFFjDkIpf

[NightHawk Biosciences @NightHawk_Bio]

Heat CEO @jeffwolfheatbio spoke to @TriBizTech at the @TriangleBIZJrnl about new "Blackhawk" biothreat subsidiary: “Covid-19 is relatively mild compared to potential biothreats on the horizon.” Full article here: https://t.co/vO3uMgMRQM

[NightHawk Biosciences @NightHawk_Bio]

Join us in welcoming former U.S. Senator Mark Pryor as the newest member of our biothreat advisory board: https://t.co/LUDwzNiaHB

[NightHawk Biosciences @NightHawk_Bio]

Proud to announce 2 members of our new biothreat advisory board: Fmr. Asst. Sec. of Defense for Nuclear, Chemical & Biological Defense Programs Andrew C. Weber, & chemical & biological weapons expert Gregory D. Koblentz, Ph.D: https://t.co/DuawVryoVk @AndyWeberNCB @gregkoblentz